Support the next development stage.
Discuss investment, licensing, development financing and long-term commercialisation opportunities in oxygen therapeutics.
Investors & Partners
Build the next generation of oxygen-delivery capability.
BHOC Therapeutics connects Biological Hemoglobin Oxygen Carrier technology, Precision Oxygenation Therapeutics and source-linked evidence with partners who can help move the field forward.
Who we welcome
Serious collaboration around a clearly defined need.
We welcome focused conversations with investors, strategic and commercial partners, clinical researchers, manufacturing organisations and regulatory partners. The appropriate structure depends on the technology, geography, development stage and evidence required.
Build regional and market pathways.
Explore partnerships for market access, distribution, technology transfer and structured regional development.
Turn evidence into execution.
Connect clinical research, GMP manufacturing, regulatory strategy, validation and translational development.
Authorized access pathway
Request access
BHOC Business Portal
A separate protected workspace is being prepared for authorized investors and partners. Public pages will explain the opportunity; confidential business materials will remain outside the public website.
- Individual access by invitation and review
- View-only or downloadable permissions
- Time-limited access, revocation and access records
Request process
Start with the right context.
When contacting BHOC Therapeutics, please identify your organisation, role, area of interest and target geography. This helps us direct the discussion to the appropriate scientific, commercial or development pathway.
We do not publish confidential materials on this page. Access to the future BHOC Business Portal will be granted individually.
Contact BHOC Therapeutics